FIELD: medicinal chemistry; pharmacology.
SUBSTANCE: invention relates to the use of ethyl ester 4-(2-methyl-6-{[2-(diphenylamino)-2-oxoethyl]thio}-4-fur-2-yl-5-cyano -1,4-dihydropyridine-3-carboxamido)benzoic acid of formula (I) as an anti-inflammatory agent.
EFFECT: advantage of using the compound of formula (I) is its more pronounced anti-inflammatory effect compared to such drugs as indomethacin, diclofenac, meloxicam and metamizole sodium.
1 cl, 3 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
2-METHYL-N-(2-METHYLPHENYL)-4-(2-FURYL)-5-CYANO-6-({2-[(4-ETHOXYPHENYL)AMINO]-2-OXOETHYL}THIO)-1,4-DIHYDROPYRIDINE-3-CARBOXAMIDE EXHIBITING ANALGESIC PROPERTIES | 2023 |
|
RU2813896C1 |
USE OF 2-METHYL-N-(2-METHYLPHENYL)-4-(2-FURYL)-5-CYANO-6-({2-[(4-ETHOXYPHENYL)AMINO]-2-OXOETHYL}THIO)-1,4 -DIHYDROPYRIDINE-3-CARBOXAMIDE AS HYPOGLYCEMIC, HYPOLIPIDEMIC AGENT THAT PROMOTES WEIGHT LOSS | 2023 |
|
RU2812569C1 |
APPLICATION OF BENZYL 6-({2-[(3,4-DIMETHYLPHENYL)AMINO]-2-OXOETHYL}THIO)-2-METHYL-4-(4-CHLOROPHENYL)-5-CYANO-1,4-DIHYDROPYRIDINE-3-CARBOXYLATE AS HEPATOPROTECTIVE AGENT | 2021 |
|
RU2755349C1 |
PHARMACEUTICALLY ACCEPTABLE SALTS OF (S)-N-[4-(1-ADAMANTYL)BENZOYL]-α-AMINO ACIDS AND SYNTHESIS METHOD THEREOF | 2009 |
|
RU2417988C2 |
USE OF 3-AMINO-4-(5-METHYL-2-FURYL)-5,6,7,8-TETRAHYDROTHIENO[2,3-b]QUINOLIN-2-yl](PHENYL)METHANONE AS ANTI-INFLAMMATORY AGENT | 2023 |
|
RU2812570C1 |
BIS{3-PHENYL-1-[2-(5-METHYL-1,3,4-THIADIAZOLYL)]CARBOXAMIDO-1,3-PROPANEDIONATO}MANGANESE HAVING ANTI-INFLAMMATORY AND ANALGESIC ACTVITY | 2008 |
|
RU2396263C2 |
2-([{4-NITROPHENYL}IMINO](PHENYL)METHYL)ISOINDOLINE-1,3-DIONE, METHOD FOR PRODUCTION THEREOF, ANALGESIC AND ANTI-INFLAMMATORY AGENT BASED THEREON | 2022 |
|
RU2789687C1 |
METHOD OF PRODUCING DERIVATIVES OF 4-OXYQUINOLINECARBOLIC ACID | 0 |
|
SU1584749A3 |
PHARMACEUTICAL COMBINATION CONTAINING 3-(3-DIMETHYLAMINO-1-ETHYL-2-METHYLPROPYL)PHENOL AND NON-STEROID ANTI-INFLAMMATORY PREPARATION | 2007 |
|
RU2465263C2 |
TOOL THAT HAS THE ABILITY TO STIMULATE REPARATIVE PROCESSES OF PERIODONTAL TISSUES, AS WELL AS AN ANTIOXIDANT AND ANTI-INFLAMMATORY EFFECT, WHICH IS A 2-ETHYL-6-METHYL-3-HYDROXYPYRIDIA-2- (3-BENZOILPHENIL)-PROPANOATE, AND A PHARMACEUTICAL COMPOSITION BASED ON IT | 2022 |
|
RU2793537C1 |
Authors
Dates
2023-03-22—Published
2022-07-08—Filed